Well what would be nice is whoever to take them over in the next month or two to have the options in the money. My money's on Alcon. We will get a true picture of how much this is actually worth in May.
Eye Care Update:
On 3 December, the Company was pleased to announce that Alcon, Inc (NYSE: ACL) had FDA approval for its TRIESENCE™ preservative free corticosteroid product for a range of
uses in the eye. AOS will shortly receive the US$1.0 million final milestone payment on the product registration and expects to receive its first royalty payment in March 2008
based on sales for the partial month of December 2007. The first full quarterly royalty is due in May 2008 for the quarter to 31 March 2008.
AOS
advanced ocular systems limited
Well what would be nice is whoever to take them over in the next...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)